Pontiro

Based in the UK, Pontiro specializes in offering independent AI evaluation and data anonymization services tailored for the healthcare sector, enhancing operational efficiency and validating clinical performance of AI products. Pontiro, founded in 2024, operates out of Newport, UK, providing services focused on independent evaluations of AI tools for the healthcare industry. The firm was established by Evan Jenkins and Lewis Bowen, with Lewis currently serving as CEO. In February 2026, Pontiro raised GBP 357,500 in venture funding led by SFC Capital, with participation from British Business Bank and Plug and Play, marking its first deal.

Pontiro specializes in independent AI evaluation and data anonymization services specifically designed for the healthcare sector. Their primary offerings include structured evaluations of AI tools to determine their clinical effectiveness and measurable return on investment (ROI). They provide recommendations on whether to scale, discontinue, or redesign AI applications based on thorough assessments conducted in real clinical environments. Moreover, Pontiro’s data anonymization service ensures the secure removal of personally identifiable information (PII) from DICOM images and clinical reports, achieving a 99.

9% accuracy rate. The company serves a diverse clientele that includes hospitals, AI vendors, and research teams across international markets, particularly in the UK and Europe, aiming to enhance the operational efficiency of healthcare organizations and validate the clinical performance of AI products. Pontiro's revenue model is driven by B2B transactions focused on healthcare organizations and AI vendors seeking independent validation of their AI tools. Their services are structured around evaluation contracts and data anonymization projects, generating income through individual evaluations, vendor readiness assessments, and subscription-based access to their anonymization technology.

Specific pricing plans for these services are tailored according to client needs, reflecting the complexity and scope of the evaluations. By ensuring a vendor-neutral stance, Pontiro fosters trust among clients, solidifying long-term partnerships and enhancing their market presence within the healthcare industry. In February 2026, Pontiro raised GBP 357,500 in venture funding, which will support the company's growth and expansion initiatives. The firm is actively designing new products and aims to expand into additional markets across Europe.

Specific targets for this expansion will be outlined in upcoming strategic plans, with a focus on enhancing their service offerings and reaching a wider client base within the healthcare sector.